.png)
Blood Collection Market By Product (edta Tubes,serum-separating Tubes, Blood Bags, Needles And Syringes, Heparin Tubes, Plasma-separating Tubes And Other Products), Application (treatment And Diagnostics) And End User (diagnostics Centres, Hospitals, Blood Banks And Other Applications)- Global Industry Analysis And Forecast To 2023
Published On : July 2018 Pages : 190 Category: Medical Devices Report Code : HC071067
SEGMENTS & REGIONS:
- By Product: edta Tubes,serum-separating Tubes, Blood Bags, Needles And Syringes, Heparin Tubes, Plasma-separating Tubes And Other Products
- Application: treatment And Diagnostics
- And End User: diagnostics Centres, Hospitals, Blood Banks And Other Applications
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Industry Outlook and Trend Analysis
The Blood Collection Market was worth USD billion in 2017 and is expected to reach approximately USD billion by 2023, while registering itself at a compound annual growth rate (CAGR) of % during the forecast period. Expanding prevalence of infectious and non-communicable sicknesses, rising number of trauma and accident cases are the main considerations contributing toward the development. Expanding number of surgeries is another main consideration significantly advancing the development of the market. As indicated by the WHO, in 2017, around 266.2 to 359.5 million surgeries were performed all inclusive and this number is anticipated to increase sooner rather than later. The expansion in the quantity of surgeries, for example, organ transplant and cancer surgeries that require blood transfusion is foreseen to drive the development of the market.
Product Outlook and Trend Analysis
In 2017, needles and syringes was the biggest income producing fragment and are additionally anticipated to maintain its strength amid the estimate time frame. The increasing demand for syringes and needles in illnesses conclusion and surgeries is the main consideration adding to the development of this portion. Also, these products are economical and easy to use. These variables drive its application for diagnostics and therapeutic purposes.
Application Outlook and Trend Analysis
The diagnostics application portion represented significant income share of the market in 2017. Different conditions, for example, cancer, infectious diseases, anemia, diabetes, and sickle cell require blood testing frequently. Therefore, the interest for blood collection products for diagnostics application is high and is anticipated to stay on the ascent all through the examination time frame.
End User Outlook and Trend Analysis
The hospitals portion is foreseen to develop at speediest rate over the figure time frame. The developing awareness regarding healthcare and additionally activities by the administration and nongovernment associations, to control and forestall infectious illnesses is a main factor in charge of the market development. For example, the CDC has started to team up with the legislature of South Africa to create national HIV clinical and research rules, lead the study of disease transmission preparing, and bolster HIV and TB programs.
Regional Outlook and Trend Analysis
The North America ruled the overall market in 2017. The existence of highly developed healthcare infrastructure and high per capita healthcare expense drive the development in this region. In addition, quick implementation of advanced products in the U.S. boosts the requirement for target products. Asia Pacific is anticipated to develop at the highest rate over the forecast period.
Competitive Insights
The leading players in the market are Qiagen, Becton Dickinson, Abbott Laboratories, Medtronic, FL MEDICAL, Becton Dickinson, Terumo Corporation and Nipro. The leading companies are adopting several organic as well as inorganic methodologies, for example, acquisitions, collaborations, new product development, and regional extension to increase greatest share in the business. For example, in March 2017, Becton, Dickinson and Company procured CareFusion Corp. to extend its product portfolio and topographical reach over the globe.
The Blood Collection Market is segmented as follows-
By Product
- EDTA Tubes
- Serum-separating Tubes
- Blood Bags
- Needles and Syringes
- Heparin Tubes
- Plasma-separating Tubes
- Others
By Application
- Treatment
- Diagnostics
By End User
- Diagnostics Centres
- Hospitals
- Blood Banks
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- South Africa
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2023?
- What will be the industry market growth from 2017 to 2023?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Blood Collection Market, By Product, Estimates and Forecast, 2014-2023($Billion)
o EDTA Tubes
o Serum-separating Tubes
o Blood Bags
o Needles and Syringes
o Heparin Tubes
o Plasma-separating Tubes
o Other Products
· Blood Collection Market, By Application, Estimates and Forecast, 2014-2023($Billion)
o Treatment
o Diagnostics
· Blood Collection Market, By End User, Estimates and Forecast, 2014-2023($Billion)
o Diagnostics Centers
o Hospitals
o Blood Banks
o Other Applications
· Blood Collection Market, By Region, Estimates and Forecast, 2014-2023($Billion)
o North America
§ North America Blood Collection Market, By Country
o U.S. Blood Collection Market
o Canada Blood Collection Market
o Mexico Blood Collection Market
o Europe
§ Europe Blood Collection Market, By Country
o Germany Blood Collection Market
o UK Blood Collection Market
o France Blood Collection Market
o Russia Blood Collection Market
o Italy Blood Collection Market
o Rest of Europe Blood Collection Market
o Asia-Pacific
§ Asia-Pacific Blood Collection Market, By Country
o China Blood Collection Market
o Japan Blood Collection Market
o South Korea Blood Collection Market
o India Blood Collection Market
o Southeast Asia Blood Collection Market
o Rest of Asia-Pacific Blood Collection Market
o South America
§ South America Blood Collection Market
o Brazil Blood Collection Market
o Argentina Blood Collection Market
o Columbia Blood Collection Market
o South Africa Blood Collection Market
o Rest of South America Blood Collection Market
o Middle East and Africa
§ Middle East and Africa Blood Collection Market
o Saudi Arabia Blood Collection Market
o UAE Blood Collection Market
o Egypt Blood Collection Market
o Nigeria Blood Collection Market
o South Africa Blood Collection Market
o Rest of MEA Blood Collection Market
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2023)
4.1.2. Canada Market States and Outlook (2017-2023)
4.1.3. Mexico Market States and Outlook (2017-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2023)
4.2.2. France Market States and Outlook (2017-2023)
4.2.3. UK Market States and Outlook (2017-2023)
4.2.4. Russia Market States and Outlook (2017-2023)
4.2.5. Italy Market States and Outlook (2017-2023)
4.2.6. Rest of Europe Market States and Outlook (2017-2023)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2023)
4.3.2. Japan Market States and Outlook (2017-2023)
4.3.3. Korea Market States and Outlook (2017-2023)
4.3.4. India Market States and Outlook (2017-2023)
4.3.5. Rest of Asia-Pacific Market States and Outlook (2017-2023)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2023)
4.4.2. Argentina Market States and Outlook (2017-2023)
4.4.3. Columbia Market States and Outlook (2017-2023)
4.4.4. Rest of South America Market States and Outlook (2017-2023)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2023)
4.5.2. UAE Market States and Outlook (2017-2023)
4.5.3. Egypt Market States and Outlook (2017-2023)
4.5.4. Nigeria Market States and Outlook (2017-2023)
4.5.5. South Africa Market States and Outlook (2017-2023)
4.5.6. Rest of MEA Market States and Outlook (2017-2023)
5. Blood Collection Market, By Product
5.1. Introduction
5.2. Global Blood Collection Sales, Revenue and Market Share by Product (2017-2027)
5.2.1. Global Blood Collection Sales and Sales Share by Product (2017-2027)
5.2.2. Global Blood Collection Revenue and Revenue Share by Product (2017-2027)
5.3. EDTA Tubes
5.3.1. Global EDTA Tubes Sales and Growth Rate (2017-2027)
5.4. Serum-separating Tubes
5.4.1. Global Serum-separating Tubes Sales and Growth Rate (2017-2027)
5.5. Blood Bags
5.5.1. Global Blood Bags Sales and Growth Rate (2017-2027)
5.6. Needles and Syringes
5.6.1. Global Needles and Syringes Sales and Growth Rate (2017-2027)
5.7. Heparin Tubes
5.7.1. Global Heparin Tubes Sales and Growth Rate (2017-2027)
5.8. Plasma-separating Tubes
5.8.1. Global Plasma-separating Tubes Sales and Growth Rate (2017-2027)
5.9. Other Products
5.9.1. Global Other Products Sales and Growth Rate (2017-2027)
6. Blood Collection Market, By Application
6.1. Introduction
6.2. Global Blood Collection Sales, Revenue and Market Share By Application (2017-2027)
6.2.1. Global Blood Collection Sales and Sales Share By Application (2017-2027)
6.2.2. Global Blood Collection Revenue and Revenue Share By Application (2017-2027)
6.3. Treatment
6.3.1. Global Treatment Sales and Growth Rate (2017-2027)
6.4. Diagnostics
6.4.1. Global Diagnostics Sales and Growth Rate (2017-2027)
7. Blood Collection Market, By End User
7.1. Introduction
7.2. Global Blood Collection Sales, Revenue and Market Share By End User (2017-2027)
7.2.1. Global Blood Collection Sales and Sales Share By End User (2017-2027)
7.2.2. Global Blood Collection Revenue and Revenue Share By End User (2017-2027)
7.3. Diagnostics Centers
7.3.1. Global Diagnostics Centers Sales and Growth Rate (2017-2027)
7.4. Hospitals
7.4.1. Global Hospitals Sales and Growth Rate (2017-2027)
7.5. Blood Banks
7.5.1. Global Blood Banks Sales and Growth Rate (2017-2027)
7.6. Other Applications
7.6.1. Global Other Applications Sales and Growth Rate (2017-2027)
8. Blood Collection Market, By Region
8.1. Introduction
8.2. Global Blood Collection Sales, Revenue and Market Share by Regions
8.2.1. Global Blood Collection Sales by Regions (2017-2027)
8.2.2. Global Blood Collection Revenue by Regions (2017-2027)
8.3. North America Blood Collection by Countries
8.3.1. North America Blood Collection Sales and Growth Rate (2017-2027)
8.3.2. North America Blood Collection Revenue and Growth Rate (2017-2027)
8.3.3. North America Blood Collection Sales by Countries (2017-2027)
8.3.4. North America Blood Collection Revenue (Million USD) by Countries (2017-2027)
8.3.5. U.S.
8.3.5.1. United States Blood Collection Sales and Growth Rate (2017-2027)
8.3.5.2. United States Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.6. Canada
8.3.6.1. Canada Blood Collection Sales and Growth Rate (2017-2027)
8.3.6.2. Canada Blood Collection Sales (Millions USD) and Growth Rate (2017-2027)
8.3.7. Mexico
8.3.7.1. Mexico Blood Collection Sales and Growth Rate (2017-2027)
8.3.7.2. Mexico Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Blood Collection by Countries
8.4.1. Europe Blood Collection Sales and Growth Rate (2017-2027)
8.4.2. Europe Blood Collection Revenue and Growth Rate (2017-2027)
8.4.3. Europe Blood Collection Sales by Countries (2017-2027)
8.4.4. Europe Blood Collection Revenue (Million USD) by Countries (2017-2027)
8.4.5. Germany
8.4.5.1. Germany Blood Collection Sales and Growth Rate (2017-2027)
8.4.5.2. Germany Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. UK
8.4.6.1. UK Blood Collection Sales and Growth Rate (2017-2027)
8.4.6.2. UK Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. France
8.4.7.1. France Blood Collection Sales and Growth Rate (2017-2027)
8.4.7.2. France Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Russia
8.4.8.1. Russia Blood Collection Sales and Growth Rate (2017-2027)
8.4.8.2. Russia Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.9. Italy
8.4.9.1. Italy Blood Collection Sales and Growth Rate (2017-2027)
8.4.9.2. Italy Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.10. Rest of Europe
8.4.10.1. Rest of Europe Blood Collection Sales and Growth Rate (2017-2027)
8.4.10.2. Rest of Europe Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific
8.5.1. Asia-Pacific Blood Collection Sales and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Blood Collection Revenue and Growth Rate (2017-2027)
8.5.3. Asia-Pacific Blood Collection Sales by Countries (2017-2027)
8.5.4. Asia-Pacific Blood Collection Revenue (Million USD) by Countries (2017-2027)
8.5.5. China
8.5.5.1. China Blood Collection Sales and Growth Rate (2017-2027)
8.5.5.2. China Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. Japan
8.5.6.1. Japan Blood Collection Sales and Growth Rate (2017-2027)
8.5.6.2. Japan Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6.3.
8.5.7. Korea
8.5.7.1. Korea Blood Collection Sales and Growth Rate (2017-2027)
8.5.7.2. Korea Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. India
8.5.8.1. India Blood Collection Sales and Growth Rate (2017-2027)
8.5.8.2. India Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.9. Southeast Asia
8.5.9.1. Southeast Asia Blood Collection Sales and Growth Rate (2017-2027)
8.5.9.2. Southeast Asia Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.10. Rest of Asia-Pacific
8.5.10.1. Rest of Asia-Pacific Blood Collection Sales and Growth Rate (2017-2027)
8.5.10.2. Rest of Asia-Pacific Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America
8.6.1. South America Blood Collection Sales and Growth Rate (2017-2027)
8.6.2. South America Blood Collection Revenue and Growth Rate (2017-2027)
8.6.3. South America Blood Collection Sales by Countries (2017-2027)
8.6.4. South America Blood Collection Revenue (Million USD) by Countries (2017-2027)
8.6.5. Brazil
8.6.5.1. Brazil Blood Collection Sales and Growth Rate (2017-2027)
8.6.5.2. Brazil Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Argentina
8.6.6.1. Argentina Blood Collection Sales and Growth Rate (2017-2027)
8.6.6.2. Argentina Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.7. Columbia
8.6.7.1. Columbia Blood Collection Sales and Growth Rate (2017-2027)
8.6.7.2. Columbia Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.8. Rest of South America
8.6.8.1. Rest of South America Blood Collection Sales and Growth Rate (2017-2027)
8.6.8.2. Rest of South America Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa
8.7.1. Middle East and Africa Blood Collection Sales and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Blood Collection Revenue and Growth Rate (2017-2027)
8.7.3. Middle East and Africa Blood Collection Sales by Countries (2017-2027)
8.7.4. Middle East and Africa Blood Collection Revenue (Million USD) by Countries (2017-2027)
8.7.5. Saudi Arabia
8.7.5.1. Saudi Arabia Blood Collection Sales and Growth Rate (2017-2027)
8.7.5.2. Saudi Arabia Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. United Arab Emirates
8.7.6.1. United Arab Emirates Blood Collection Sales and Growth Rate (2017-2027)
8.7.6.2. United Arab Emirates Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. Egypt
8.7.7.1. Egypt Blood Collection Sales and Growth Rate (2017-2027)
8.7.7.2. Egypt Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Nigeria
8.7.8.1. Nigeria Blood Collection Sales and Growth Rate (2017-2027)
8.7.8.2. Nigeria Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. South Africa
8.7.9.1. South Africa Blood Collection Sales and Growth Rate (2017-2027)
8.7.9.2. South Africa Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.10. Rest of Middle East and Africa
8.7.10.1. Rest of Middle East and Africa Blood Collection Sales and Growth Rate (2017-2027)
8.7.10.2. Rest of Middle East and Africa Blood Collection Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Abbott Laboratories
9.1.1. Business Overview
9.1.2. Product Portfolio
9.1.3. Strategic Developments
9.1.4. Sales, Revenue and Market Share
9.2. NIPRO Medical Corp.
9.2.1. Business Overview
9.2.2. Product Portfolio
9.2.3. Strategic Developments
9.2.4. Sales, Revenue and Market Share
9.3. Becton, Dickinson and Company
9.3.1. Business Overview
9.3.2. Product Portfolio
9.3.3. Strategic Developments
9.3.4. Sales, Revenue and Market Share
9.4. Terumo Corp.
9.4.1. Business Overview
9.4.2. Product Portfolio
9.4.3. Strategic Developments
9.4.4. Sales, Revenue and Market Share
9.5. Medtronic
9.5.1. Business Overview
9.5.2. Product Portfolio
9.5.3. Strategic Developments
9.5.4. Sales, Revenue and Market Share
9.6. Qiagen
9.6.1. Business Overview
9.6.2. Product Portfolio
9.6.3. Strategic Developments
9.6.4. Sales, Revenue and Market Share
9.7. FL MEDICAL s.r.l.
9.7.1. Business Overview
9.7.2. Product Portfolio
9.7.3. Strategic Developments
9.7.4. Sales, Revenue and Market Share
9.8. Greiner Holding AG
9.8.1. Business Overview
9.8.2. Product Portfolio
9.8.3. Strategic Developments
9.8.4. Sales, Revenue and Market Share
9.9. Haemonetics Corp.
9.9.1. Business Overview
9.9.2. Product Portfolio
9.9.3. Strategic Developments
9.9.4. Sales, Revenue and Market Share
9.10. Sarstedt AG & Co.
9.10.1. Business Overview
9.10.2. Product Portfolio
9.10.3. Strategic Developments
9.10.4. Sales, Revenue and Market Share
10. Global Blood Collection Market Competition, by Manufacturer
10.1. Global Blood Collection Sales and Market Share by Manufacturer (2017-2017)
10.2. Global Blood Collection Revenue and Market Share by Manufacturer (2017-2017)
10.3. Global Blood Collection Price by Manufacturer (2017-2017)
10.4. Top 5 Blood Collection Manufacturer Market Share
10.5. Market Competition Trend
11. Blood Collection Market Forecast (2027-2023)
11.1. Global Blood Collection Sales, Revenue (Millions USD) and Growth Rate (2027-2023)
11.2. Blood Collection Market Forecast by Regions (2027-2023)
11.2.1. North America Blood Collection Market Forecast (2027-2023)
11.2.1.1. United States Blood Collection Market Forecast (2027-2023)
11.2.1.2. Canada Blood Collection Market Forecast (2027-2023)
11.2.1.3. Mexico Blood Collection Market Forecast (2027-2023)
11.2.2. Europe Blood Collection Market Forecast (2027-2023)
11.2.2.1. Germany Blood Collection Market Forecast (2027-2023)
11.2.2.2. United Kingdom Blood Collection Market Forecast (2027-2023)
11.2.2.3. France Blood Collection Market Forecast (2027-2023)
11.2.2.4. Russia Blood Collection Market Forecast (2027-2023)
11.2.2.5. Italy Blood Collection Market Forecast (2027-2023)
11.2.2.6. Rest of the Europe Blood Collection Market Forecast (2027-2023)
11.2.3. Asia-Pacific Blood Collection Market Forecast (2027-2023)
11.2.3.1. China Blood Collection Market Forecast (2027-2023)
11.2.3.2. Japan Blood Collection Market Forecast (2027-2023)
11.2.3.3. Korea Blood Collection Market Forecast (2027-2023)
11.2.3.4. India Blood Collection Market Forecast (2027-2023)
11.2.3.5. Southeast Asia Blood Collection Market Forecast (2027-2023)
11.2.3.6. Rest of Asia-Pacific Blood Collection Market Forecast (2027-2023)
11.2.4. South America Blood Collection Market Forecast (2027-2023)
11.2.4.1. Brazil Blood Collection Market Forecast (2027-2023)
11.2.4.2. Argentina Blood Collection Market Forecast (2027-2023)
11.2.4.3. Columbia Blood Collection Market Forecast (2027-2023)
11.2.4.4. Rest of South America Blood Collection Market Forecast (2027-2023)
11.2.5. Middle East and Africa Blood Collection Market Forecast (2027-2023)
11.2.5.1. Saudi Arabia Blood Collection Market Forecast (2027-2023)
11.2.5.2. UAE Blood Collection Market Forecast (2027-2023)
11.2.5.3. Egypt Blood Collection Market Forecast (2027-2023)
11.2.5.4. Nigeria Blood Collection Market Forecast (2027-2023)
11.2.5.5. South Africa Blood Collection Market Forecast (2027-2023)
11.2.5.6. Rest of MEA Blood Collection Market Forecast (2027-2023)
11.3. Blood Collection Market Forecast by Product (2027-2023)
11.3.1. Global Blood Collection Sales Forecast by Product (2027-2023)
11.3.2. Global Blood Collection Sales Market Share Forecast by Product (2027-2023)
11.4. Blood Collection Market Forecast By Application (2027-2023)
11.4.1. Global Blood Collection Sales Forecast By Application (2027-2023)
11.4.2. Global Blood Collection Sales Market Share Forecast By Application (2027-2023)
11.5. Blood Collection Market Forecast By End User (2027-2023)
11.5.1. Global Blood Collection Sales Forecast By End User (2027-2023)
11.5.2. Global Blood Collection Sales Market Share Forecast By End User (2027-2023)
List of Tables
*You can glance through the list of Tables and Figures when you view the sample copy of Blood Collection Market.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|